Search NEWSROOM 2017 NEWS RELEASES 2017 | 2016 | 2015 | 2014 | 2013 Mallinckrodt To Sell Intrathecal Therapy Business To Piramal Enterprises Limited For Approximately $203 Million Mallinckrodt Completes Sale Of Its Nuclear Imaging Business To IBA Molecular For Approximately $690 Million Mallinckrodt To Present At Leerink Partners 6th Annual Global Healthcare Conference Mallinckrodt And Federal Trade Commission Resolve Questcor Matter Mallinckrodt Responds to Media Reports Regarding Previously Disclosed FTC Investigation Karen Sheehy to Succeed Raymond Furey as Chief Compliance Officer of Mallinckrodt Print Page | RSS Feeds Email Alerts Contact Media Relations Our Commitment To providing safe and effective medications for the treatment of patients in pain. Responsible Use Our Culture From philanthropic efforts to advocacy initiatives, we are living our hallmarks throughout our communities. Learn How Other Links: Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2017 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Blog LinkedIn YouTube

Search KNEELAND YOUNGBLOOD, M.D. Board of Directors Kneeland Youngblood, M.D. Director Dr. Youngblood has been a director since June 2013. He is a member of Mallinckrodt’s Compliance Committee and the Nominating and Governance Committee. Dr. Youngblood is a founding partner of Pharos Capital Group. He has been serving as a director of Energy Future Holdings Corp. since 2007 and is also a member of the Council on Foreign Relations. Dr. Youngblood served as a director of Gap Inc. from 2006 to 2012, a director of Starwood Hotels and Resorts from 2001 to 2012, a director of Burger King Corporation from 2004 to 2010 and a director of iStar Financial from 1998 to 2001. He is a physician by training, with over 15 years of experience in emergency medicine. Dr. Youngblood earned a bachelor’s in politics from Princeton University and his medical degree from the University of Texas Southwestern Medical School. Back Building On Our Heritage Nearly 150 years of quality, integrity and service. Learn More Our Culture From philanthropic efforts to advocacy initiatives, we are living our hallmarks throughout our communities. Learn How Other Links: Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2017 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Blog LinkedIn YouTube